Table of Contents PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT PART 03: RESEARCH METHODOLOGY PART 04: MARKET LANDSCAPE • Market ecosystem • Market characteristics • Market segmentation analysis PART 05: MARKET SIZING • Market definition • Market sizing 2017 • Market size and forecast 2017-2022 PART 06: FIVE FORCES ANALYSIS • Bargaining power of buyers • Bargaining power of suppliers • Threat of new entrants • Threat of substitutes • Threat of rivalry • Market condition PART 07: MARKET SEGMENTATION BY PRODUCT • Segmentation by product • Comparison by product • Global vision care – Market size and forecast 2017-2022 • Global ophthalmology surgical devices – Market size and forecast 2017-2022 • Global ophthalmology diagnostic devices – Market size and forecast 2017-2022 • Market opportunity by product PART 08: CUSTOMER LANDSCAPE PART 09: MARKET SEGMENTATION BY END-USER • Segmentation by end-user • Hospitals and ophthalmology clinics • Optical retail centers • ASCs PART 10: REGIONAL LANDSCAPE • Geographical segmentation • Regional comparison • Americas – Market size and forecast 2017-2022 • EMEA – Market size and forecast 2017-2022 • APAC – Market size and forecast 2017-2022 • Market opportunity PART 11: DECISION FRAMEWORK PART 12: DRIVERS AND CHALLENGES • Market drivers • Market challenges PART 13: MARKET TRENDS • Increasing number of strategic M&A • Increasing number of partnerships • Focus on promotional sales PART 14: VENDOR LANDSCAPE • Overview • Landscape disruption • Competitive landscape PART 15: VENDOR ANALYSIS • Vendors covered • Vendor classification • Market positioning of vendors • Carl Zeiss Meditec • Essilor • HOYA • Johnson & Johnson • NIDEK • Novartis • TOPCON • Valeant Pharmaceuticals International • Other prominent vendors PART 16: APPENDIX • List of abbreviations List of Exhibits Exhibit 01: Global medical devices market Exhibit 02: Global medical devices market Exhibit 03: Market characteristics Exhibit 04: Global ophthalmology devices market segments Exhibit 05: Global ophthalmology devices market definition - Inclusions and exclusions checklist Exhibit 06: Global ophthalmology devices market size 2017 Exhibit 07: Validation techniques employed for market sizing 2017 Exhibit 08: Global ophthalmology devices market – Market size and forecast 2017-2022 ($ bn) Exhibit 09: Global ophthalmology devices market– Year over year growth 2018-2022 (%) Exhibit 10: Five forces analysis 2017 Exhibit 11: Five forces analysis 2022 Exhibit 12: Bargaining power of buyers Exhibit 13: Bargaining power of suppliers Exhibit 14: Threat of new entrants Exhibit 15: Threat of substitutes Exhibit 16: Threat of rivalry Exhibit 17: Market condition - Five forces 2017 Exhibit 18: Product – Market share 2017-2022 (%) Exhibit 19: Comparison by product Exhibit 20: Global vision care – Market size and forecast 2017-2022 ($ bn) Exhibit 21: Global vision care – Year over year growth 2018-2022 (%) Exhibit 22: Global ophthalmology surgical devices – Market size and forecast 2017-2022 ($ bn) Exhibit 23: Global ophthalmology surgical devices – Year over year growth 2018-2022 (%) Exhibit 24: Global ophthalmology diagnostic devices – Market size and forecast 2017-2022 ($ bn) Exhibit 25: Global ophthalmology diagnostic devices – Year over year growth 2018-2022 (%) Exhibit 26: Market opportunity by product Exhibit 27: Customer landscape Exhibit 28: Global ophthalmology devices market by end-users (%) in 2017 Exhibit 29: Global ophthalmology devices market share by geography 2017-2022 (%) Exhibit 30: Global ophthalmology devices market: Regional comparison Exhibit 31: Americas – Market size and forecast 2017-2022 ($ bn) Exhibit 32: Americas – Year over year growth 2018-2022 (%) Exhibit 33: Top 3 countries in Americas Exhibit 34: EMEA – Market size and forecast 2017-2022 ($ bn) Exhibit 35: EMEA – Year over year growth 2018-2022 (%) Exhibit 36: Top 3 countries in EMEA Exhibit 37: APAC – Market size and forecast 2017-2022 ($ bn) Exhibit 38: APAC – Year over year growth 2018-2022 (%) Exhibit 39: Top 3 countries in APAC Exhibit 40: Global ophthalmology devices market opportunity Exhibit 41: Market impact analysis: Increasing number of eye diseases in few regions Exhibit 42: Market impact analysis: Product launches Exhibit 43: Market impact analysis: Strategic M&A Exhibit 44: Market impact: Upcoming M&A Exhibit 45: Vendor landscape Exhibit 46: Landscape disruption Exhibit 47: Competitive structure analysis of global ophthalmology devices market 2017 Exhibit 48: Vendors covered Exhibit 49: Vendor classification Exhibit 50: Market positioning of vendors Exhibit 51: Carl Zeiss Meditec – Overview Exhibit 52: Carl Zeiss Meditec: Business segments Exhibit 53: Carl Zeiss Meditec: Organizational developments Exhibit 54: Carl Zeiss Meditec: Geographic focus Exhibit 55: Carl Zeiss Meditec: Segment focus Exhibit 56: Carl Zeiss Meditec: Key offerings Exhibit 57: Carl Zeiss Meditec: Key customers Exhibit 58: Essilor: Overview Exhibit 59: Essilor: Business segments Exhibit 60: Essilor: Organizational developments Exhibit 61: Essilor: Geographic focus Exhibit 62: Essilor: Segment focus Exhibit 63: Essilor: Key offerings Exhibit 64: Essilor: Key customers Exhibit 65: HOYA: overview Exhibit 66: HOYA: Business segments Exhibit 67: HOYA– Organizational developments Exhibit 68: HOYA – Geographic focus Exhibit 69: HOYA – Segment focus Exhibit 70: HOYA: Key offerings Exhibit 71: HOYA: Key customers Exhibit 72: Johnson & Johnson: Overview Exhibit 73: Johnson & Johnson: Business segments Exhibit 74: Johnson & Johnson: Organizational developments Exhibit 75: Johnson & Johnson: Geographic focus Exhibit 76: Johnson & Johnson: Segment focus Exhibit 77: Johnson & Johnson: Key offerings Exhibit 78: Johnson & Johnson: Key customers Exhibit 79: NIDEK: Overview Exhibit 80: NIDEK: Business segments Exhibit 81: NIDEK: Organizational developments Exhibit 82: NIDEK – Geographic focus Exhibit 83: NIDEK – Segment focus Exhibit 84: NIDEK: Key offerings Exhibit 85: NIDEK: Key customers Exhibit 86: Novartis: Overview Exhibit 87: Novartis: Business segments Exhibit 88: Novartis: Organizational developments Exhibit 89: Novartis: Geographic focus Exhibit 90: Novartis: Segment focus Exhibit 91: Novartis: Key offerings Exhibit 92: Novartis: Key customers Exhibit 93: TOPCON – Overview Exhibit 94: TOPCON: Business segments Exhibit 95: TOPCON: Organizational developments Exhibit 96: TOPCON – Geographic focus Exhibit 97: TOPCON – Segment focus Exhibit 98: TOPCON: Key offerings Exhibit 99: TOPCON: Key customers Exhibit 100: Valeant Pharmaceuticals International overview Exhibit 101: Valeant Pharmaceuticals International: Business segments Exhibit 102: Valeant Pharmaceuticals International – Organizational developments Exhibit 103: Valeant Pharmaceuticals International – Geographic focus Exhibit 104: Valeant Pharmaceuticals International – Segment focus Exhibit 105: Valeant Pharmaceuticals International: Key offerings Exhibit 106: Valeant Pharmaceuticals International: Key customers

Carl Zeiss Meditec, Essilor, HOYA, Johnson & Johnson, NIDEK, Novartis, TOPCON, Valeant Pharmaceuticals International.